Articles with public access mandates - Jose A. Garcia Marco ORCID:0000-0002-8993-5982Learn more
Not available anywhere: 3
Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the …
N Purroy, J Bergua, L Gallur, J Prieto, LA Lopez, JM Sancho, ...
British journal of haematology 169 (2), 188-198, 2015
Mandates: Government of Spain
In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
M Martinez-Moreno, M Leiva, N Aguilera-Montilla, S Sevilla-Movilla, ...
Leukemia 30 (4), 861-872, 2016
Mandates: Government of Spain
Sequential optimisation of yield and sensory quality of semi-hard cheese manufactured from a mixture of ultrafiltered ewes' and cows' milk
D Delgado, G Salazar, M García
International Dairy Journal 32 (2), 89-98, 2013
Mandates: Government of Spain
Available somewhere: 30
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
S Horwitz, OA O'Connor, B Pro, T Illidge, M Fanale, R Advani, NL Bartlett, ...
The Lancet 393 (10168), 229-240, 2019
Mandates: US National Institutes of Health, National Institute for Health Research, UK …
Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial
JC Byrd, P Hillmen, P Ghia, AP Kater, A Chanan-Khan, RR Furman, ...
Journal of clinical oncology 39 (31), 3441-3452, 2021
Mandates: US National Institutes of Health
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
AR Mato, LE Roeker, N Lamanna, JN Allan, L Leslie, JM Pagel, K Patel, ...
Blood, The Journal of the American Society of Hematology 136 (10), 1134-1143, 2020
Mandates: US National Institutes of Health, National Institute for Health Research, UK
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ...
Leukemia 34 (9), 2354-2363, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
PLCG1 mutations in cutaneous T-cell lymphomas
JP Vaqué, G Gómez-López, V Monsálvez, I Varela, N Martínez, C Pérez, ...
Blood, The Journal of the American Society of Hematology 123 (13), 2034-2043, 2014
Mandates: Government of Spain
Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain
J Redondo-Muñoz, E Ugarte-Berzal, MJ Terol, PE Van den Steen, ...
Cancer cell 17 (2), 160-172, 2010
Mandates: Research Foundation (Flanders), German Research Foundation
α4β1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
J Redondo-Munoz, E Ugarte-Berzal, JA García-Marco, MH del Cerro, ...
Blood, The Journal of the American Society of Hematology 112 (1), 169-178, 2008
Mandates: Research Foundation (Flanders)
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ...
Leukemia 35 (12), 3444-3454, 2021
Mandates: Government of Spain
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
P Abrisqueta, N Villamor, MJ Terol, E González-Barca, M González, ...
Blood, The Journal of the American Society of Hematology 122 (24), 3951-3959, 2013
Mandates: Government of Spain
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
LE Roeker, TA Eyre, MC Thompson, N Lamanna, AR Coltoff, MS Davids, ...
Blood, The Journal of the American Society of Hematology 138 (18), 1768-1773, 2021
Mandates: US National Institutes of Health, National Institute for Health Research, UK …
Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders
M Kwon, G Bautista, P Balsalobre, I Sánchez-Ortega, D Serrano, ...
Biology of Blood and Marrow Transplantation 20 (12), 2015-2022, 2014
Mandates: Government of Spain
New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing
E Doménech, G Gómez-López, D Gzlez-Peña, M López, B Herreros, ...
PloS one 7 (6), e38158, 2012
Mandates: Government of Spain
VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase–9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration
E Ugarte-Berzal, J Redondo-Munoz, P Eroles, MH Del Cerro, ...
Blood, The Journal of the American Society of Hematology 115 (4), 846-849, 2010
Mandates: Research Foundation (Flanders)
A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells
E Ugarte-Berzal, E Bailón, I Amigo-Jiménez, CL Vituri, MH del Cerro, ...
Journal of Biological Chemistry 287 (33), 27601-27613, 2012
Mandates: Government of Spain
MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest
N Aguilera-Montilla, E Bailón, R Uceda-Castro, E Ugarte-Berzal, A Santos, ...
Oncogene 38 (23), 4605-4619, 2019
Mandates: Research Foundation (Flanders), Government of Spain
Activated allogeneic NK cells preferentially kill poor prognosis B-cell chronic lymphocytic leukemia cells
D Sánchez-Martínez, PM Lanuza, N Gómez, A Muntasell, E Cisneros, ...
Frontiers in immunology 7, 454, 2016
Mandates: Government of Spain
Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen
E Bailón, E Ugarte-Berzal, I Amigo-Jiménez, P Van den Steen, ...
Journal of leukocyte biology 96 (2), 185-199, 2014
Mandates: Research Foundation (Flanders), Government of Spain
Publication and funding information is determined automatically by a computer program